First Use of HeartMate 3 in a Failing Fontan Circulation

The Annals of Thoracic Surgery
Angela LortsDavid L S Morales

Abstract

The failing Fontan circulation can be challenging to support with ventricular assist devices, mostly because of the variety of causes of failure, some of which cannot be addressed by VAD therapy alone. A new ventricular assist device, the HeartMate 3 (Abbott, Chicago, IL), was recently approved for use in adults in the United States and is now widely available, with excellent survival results in two-ventricle patients. This case report describes the first successful implantation of the HeartMate 3 in a 22-year-old man with a failing Fontan circulation and the possible benefits this device may have in supporting this ever-growing population of young adults with single ventricles.

Citations

Mar 23, 2019·Artificial Organs·Kiyotaka FukamachiTakuma Miyamoto
May 31, 2020·Heart Failure Reviews·James MonacoPrateeti Khazanie
Mar 10, 2020·Circulation Journal : Official Journal of the Japanese Circulation Society·Maruti HaranalOsami Honjo
Nov 15, 2020·Heart·Leigh Reardon, Jeannette Lin
Mar 2, 2021·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Ari CedarsM Zinn
May 5, 2021·World Journal for Pediatric & Congenital Heart Surgery·Kyle W RiggsDavid L S Morales
Jun 13, 2021·Seminars in Thoracic and Cardiovascular Surgery. Pediatric Cardiac Surgery Annual·Chet R VillaDavid L S Morales
Jul 2, 2021·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Angela LortsAntonio Amodeo
Jul 16, 2021·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Nicholas A SzugyeRyan A Moore
Oct 30, 2021·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Tanya PerryChet R Villa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Related Papers

ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs
Yaron D BaracCarmelo A Milano
Journal of the Formosan Medical Association = Taiwan Yi Zhi
Yi-Shiuan LinAnne Chao
© 2022 Meta ULC. All rights reserved